China Therapeutic Ultrasound Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Therapeutic Ultrasound Market was valued at USD 538.0 million in 2025 and is projected to reach USD 782.62 million by 2032, growing at a CAGR of approximately 5.5% during 2026–2032.
China Therapeutic Ultrasound Market Highlights
| Report Metric | Details |
| Report Name | China Therapeutic Ultrasound Market |
| Market Size 2025 | USD 538.0 million |
| Market Size 2032 | USD 782.62 million |
| Absolute Growth 2025–2032 | USD 244.62 million |
| CAGR 2026–2032 | 5.5% |
| Peak Annual Growth | 8.2% in 2032 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Therapy Type, 2025 | High-Intensity Focused (38% share) |
| Leading Modality, 2025 | Non-invasive (37% share) |
| Leading Application Area, 2025 | Tumor Ablation (46% share) |
| Leading End User, 2025 | Cancer Centers (44% share) |
| Fastest-Growing Therapy Type | Low-Intensity Pulsed (6.7% CAGR) |
| Fastest-Growing Modality | Targeted Therapy (7.8% CAGR) |
| Fastest-Growing Application Area | Bone Healing (8.1% CAGR) |
| Fastest-Growing End User | Orthopedic Clinics (6.6% CAGR) |
| Growing Sector | Cancer treatment |
| Key End Users | Cancer Centers, Orthopedic Clinics, Urology Units, Neuro Clinics |
China Therapeutic Ultrasound Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Annual growth estimates for each year appear below with the principal reason behind them, explaining the shifts that set the pace of the market.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 5.9 | The market experienced solid growth due to increased adoption of non-invasive therapies in hospitals. |
| 2023 | 3.4 | Growth slowed as hospitals adjusted to new treatment protocols and technologies, impacting patient volume. |
| 2024 | 5.3 | The market rebounded with healthcare facilities investing more in advanced ultrasound systems for treatment. |
| 2025 | 3.3 | A slowdown occurred as budget constraints limited hospital spending on new technologies and equipment. |
| 2026 | 7.5 | Growth is expected to accelerate as the demand for targeted therapies gains momentum in hospitals. |
| 2027 | 4.1 | The market is projected to slow again as healthcare providers face ongoing supply chain challenges. |
| 2028 | 3.3 | Growth is expected to continue decelerating as hospitals focus on cost management strategies. |
| 2029 | 6.7 | Demand is projected to surge as more cancer centers expand their treatment capabilities with advanced technologies. |
| 2030 | 3.8 | Growth is expected to slow as regulatory approvals for new devices take longer than anticipated. |
| 2031 | 5.0 | The market is projected to rebound with increased investment in advanced medical technologies and infrastructure. |
| 2032 | 8.2 | Growth is expected to peak as the government pushes for wider adoption of therapeutic ultrasound in healthcare. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Therapeutic Ultrasound Market Synopsis
The China Therapeutic Ultrasound Market encompasses non-invasive technologies that use sound waves for medical treatments. This technology is primarily used for tumor ablation, kidney stone treatment, and bone healing. The market is expanding due to rising demand from healthcare facilities and hospitals, driven by initiatives like the 'Healthy China 2030' programme. In 2023, the government allocated 1 billion CNY for advanced medical technologies, improving the availability of therapeutic ultrasound. With over 1,000 cancer centers in operation, the market is set for significant growth through 2032.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increased investment in healthcare infrastructure | Driver | High | Tumor Ablation |
| Growing demand for non-invasive treatment options | Driver | High | Lithotripsy Ultrasound |
| Rising number of cancer centers adopting advanced therapies | Opportunity | High | Cancer Centers |
| Expansion of orthopedic clinics adopting ultrasound technology | Opportunity | High | Orthopedic Clinics |
| Budget constraints in hospitals limiting technology upgrades | Restraint | High | Cancer Centers |
| Regulatory delays in device approvals affecting market entry | Restraint | Medium | Lithotripsy Ultrasound |
| Supply chain disruptions impacting equipment availability | Challenge | High | Neuromodulation |
| High costs associated with advanced ultrasound technologies | Challenge | Medium | Bone Healing |
Evaluation of Drivers in China Therapeutic Ultrasound Market (2026–2032)
The table below links each growth driver to the segment it affects and the evidence for it.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Investment in healthcare infrastructure | Tumor Ablation | China has over 1,000 cancer centers utilizing therapeutic ultrasound for tumor ablation, increasing treatment availability. |
| Demand for non-invasive treatments | Lithotripsy Ultrasound | In 2022, approximately 5 million patients received treatment for kidney stones using lithotripsy ultrasound, indicating strong end-use demand. |
| Increase in patient volume at cancer centers | Cancer Centers | The average population served by a cancer center in China is around 500,000 individuals, driving higher treatment demand. |
| Adoption of advanced technologies in orthopedic clinics | Orthopedic Clinics | In 2023, over 300 orthopedic clinics reported using therapeutic ultrasound for patient treatments, reflecting a shift in treatment approaches. |
| Support from medical associations for ultrasound applications | Neuromodulation | The Chinese Urological Association supports the use of shock wave therapy for kidney stones in clinical guidelines, enhancing acceptance. |
The Therapeutic Ultrasound market in China is growing as investment in healthcare infrastructure, rising patient volumes, and greater adoption of non-invasive treatments drive demand. With over 1,000 cancer centres employing therapeutic ultrasound for tumor ablation, the market is experiencing heightened activity. In 2022, around 5 million patients received lithotripsy ultrasound treatments for kidney stones, indicating strong end-use demand. More than 300 orthopedic clinics are increasingly using therapeutic ultrasound for bone healing, reflecting a shift in treatment approaches. Support from medical associations further strengthens the credibility and acceptance of ultrasound technologies in clinical settings, creating a favourable environment for growth.
Evaluation of Restraints in China Therapeutic Ultrasound Market
The table below lists the restraints and the evidence behind each.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Budget constraints limiting hospital technology upgrades | Cancer Centers | The average treatment cost for kidney stones using ultrasound is around 10,000 CNY per patient, affecting affordability. |
| Regulatory delays affecting new device approvals | Lithotripsy Ultrasound | Therapeutic ultrasound devices are classified under Class II medical devices by the National Medical Products Administration, extending approval timelines. |
| Supply chain disruptions impacting equipment availability | Neuromodulation | In 2023, the installed base of therapeutic ultrasound devices in hospitals reached 15,000 units nationwide, highlighting equipment shortages. |
| High costs associated with advanced ultrasound technologies | Bone Healing | The average treatment session duration for tumor ablation is approximately 45 minutes, increasing operational costs for clinics. |
| Limited awareness among healthcare providers | Tumor Ablation | The Chinese Society of Ultrasound in Medicine is actively involved in promoting therapeutic ultrasound applications, indicating a need for education. |
China Therapeutic Ultrasound Market Challenges
China's therapeutic ultrasound market faces supply chain disruptions due to reliance on imported components, resulting in lead times of up to three months for hospitals. Regulatory compliance with ISO 13485 can delay the introduction of new devices by as much as six months, impacting healthcare facilities' ability to offer the latest treatments. The average treatment cost for kidney stones is around 10,000 CNY, limiting access for many patients, particularly in rural areas. Buyers, including clinics and hospitals, encounter inconsistent availability of advanced technologies, complicating treatment schedules and affecting patient care quality.
Trends in the China Therapeutic Ultrasound Market
Buyers and suppliers in the China Therapeutic Ultrasound Market are adjusting to the following trends.
- Shift Towards Non-Invasive Treatments: In 2023, the Chinese government allocated 1 billion CNY for advanced medical technologies, including therapeutic ultrasound. This funding is expected to improve the availability of non-invasive treatment options in hospitals.
- Growing Adoption in Orthopedic Clinics: Orthopedic clinics in major cities like Beijing and Shanghai are increasingly adopting low-intensity pulsed ultrasound for bone healing. In 2023, over 300 clinics reported using this technology, reflecting a shift in treatment approaches.
- Expansion of Cancer Centers: The number of cancer centres in China is rising, with over 1,000 currently utilising therapeutic ultrasound for tumor ablation. This growth indicates a strong demand for advanced cancer treatment options.
- Increased Focus on Targeted Therapies: The market is shifting towards targeted therapies, with the government aiming to increase adoption by 20% by 2025. This initiative highlights the growing importance of precision medicine in therapeutic ultrasound.
Investment Opportunities in the China Therapeutic Ultrasound Market
Several openings in the China Therapeutic Ultrasound Market merit attention from investors.
- Gap in Advanced Treatment Technologies: With the market projected to reach USD 782.62 million by 2032, there is an opportunity for suppliers of therapeutic ultrasound devices. Cancer centres are actively seeking solutions to improve treatment efficacy.
- Demand from Cancer Centers: Cancer centres are increasingly investing in advanced ultrasound technologies, creating a demand for high-quality devices. Collaborating with local partners can facilitate market entry and expansion.
- Timing for Investment: As the market is set to grow significantly, investing in therapeutic ultrasound technology now can yield high returns. The government's focus on enhancing non-invasive treatments presents a timely opportunity.
- Supply of Non-Invasive Solutions: There is a growing need for non-invasive treatment options in hospitals, with the government promoting these therapies. Suppliers can enter the market by obtaining necessary certifications and partnering with healthcare facilities.
Government Initiatives in the China Therapeutic Ultrasound Market
In 2023, the Ministry of Health launched the 'Healthy China 2030' initiative, aiming to improve the availability of non-invasive treatments in healthcare facilities. This measure builds on previous laws by promoting the integration of advanced medical technologies across the country, ensuring better access for patients and providers alike. The initiative facilitates the adoption of therapeutic ultrasound technologies in hospitals nationwide, improving treatment options for healthcare providers and patients.
The National Medical Products Administration oversees the approval of therapeutic ultrasound devices classified as Class II medical devices. This agency ensures that products meet safety and efficacy standards, facilitating smoother market entry for manufacturers. In 2023, the Ministry of Science and Technology allocated 500 million CNY for research into advanced ultrasound applications, supporting innovation in the field. This funding allows producers to develop and introduce new technologies to the market more efficiently, improving treatment options for patients.
Future Insight of the China Therapeutic Ultrasound Market
The therapeutic ultrasound market in China will undergo substantial changes by 2032, driven by the 'Healthy China 2030' initiative that aims to enhance access to non-invasive treatments. By 2025, hospitals are expected to increase the adoption of targeted therapies by 20%, expanding patient options. The government's allocation of 1 billion CNY for advanced medical technologies will stimulate innovations in therapeutic ultrasound. Additionally, the growing number of orthopedic clinics adopting low-intensity pulsed ultrasound will improve treatment accessibility for bone healing.
Market Segmentation Analysis
Each segment group is reviewed below, with the leader by share and the fastest grower by CAGR.
By Therapy Type – High-Intensity Focused Dominated, Low-Intensity Pulsed Expected to Grow Fastest
According to Vasudha, AM at 6Wresearch, High-Intensity Focused accounted for a 38% market share by therapy type in 2025. High-Intensity Focused ultrasound holds the largest market share as it is critical for precise tumor ablation procedures in cancer treatment. Its widespread use in over 1,000 cancer centers across China underscores its established significance in the healthcare system. Low-Intensity Pulsed is set to record the highest CAGR in this split, 6.7% over 2026–2032. The Low-Intensity Pulsed segment is experiencing rapid growth, particularly as orthopedic clinics in major cities adopt it for bone healing. This trend is driven by the increasing focus on non-invasive therapies, supported by initiatives from the National Health Commission. Suppliers should enhance their product portfolios in both high-intensity and low-intensity ultrasound technologies to meet the growing demand in these segments.
By Modality – Non-invasive Dominated, Targeted Therapy Expected to Grow Fastest
Non-invasive held a 37% share of the China Therapeutic Ultrasound Market by modality in 2025. The Non-invasive modality holds the largest market share as it aligns with the growing preference for less invasive treatment options in healthcare facilities. The National Health Commission's promotion of non-invasive therapies across 31 provinces further supports this trend. Over 2026–2032, Targeted Therapy is expected to post the fastest growth, at a CAGR of 7.8%. Targeted Therapy is the fastest-growing modality, driven by its ability to concentrate on specific tissues for treatment, thereby improving patient outcomes. The government's aim to increase targeted therapy adoption by 20% by 2025 highlights its increasing significance. Buyers should invest in non-invasive and targeted therapy technologies to remain competitive in the healthcare market.
By Application Area – Tumor Ablation Dominated, Bone Healing Expected to Grow Fastest
With a 46% revenue share in 2025, Tumor Ablation was the largest application area category. Tumor Ablation is the leading application area, capturing the largest market share due to its essential role in cancer treatment. The high number of patients receiving treatment for tumors highlights the ongoing demand for effective therapeutic ultrasound solutions in China. The quickest growth will come from Bone Healing, forecast to expand at a CAGR of 8.1% between 2026 and 2032. Bone Healing is the fastest-growing application area, with a notable rise in its use among orthopedic clinics for promoting healing. The increasing adoption of low-intensity pulsed ultrasound in these clinics reflects a shift towards supportive therapies in orthopedics. Suppliers should prioritise the development of solutions for tumor ablation and bone healing to capitalise on these significant application areas.
By End User – Cancer Centers Dominated, Orthopedic Clinics Expected to Grow Fastest
The largest end user category in 2025 was Cancer Centers, with a 44% share of total revenue. Cancer Centers are the primary end users of therapeutic ultrasound, commanding the largest market share due to their crucial role in cancer treatment. Serving an average population of around 500,000 individuals each, these centers significantly influence the healthcare landscape. Orthopedic Clinics are projected to grow fastest, at a CAGR of 6.6% during 2026–2032. Orthopedic Clinics represent the fastest-growing end user segment, increasingly utilising therapeutic ultrasound for bone healing. The rise in the number of clinics adopting this technology indicates a trend towards non-invasive treatment options in orthopedics. Suppliers should tailor their marketing strategies to effectively address the specific needs of cancer centers and orthopedic clinics to maximise their market reach.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Therapeutic Ultrasound Market Outlook
- Market Size of China Therapeutic Ultrasound Market, 2025
- Forecast of China Therapeutic Ultrasound Market, 2032
- Historical Data and Forecast of China Therapeutic Ultrasound Revenues & Volume for the Period 2022 - 2032F
- China Therapeutic Ultrasound Market Trend Evolution
- China Therapeutic Ultrasound Market Drivers and Challenges
- China Therapeutic Ultrasound Price Trends
- China Therapeutic Ultrasound Porter's Five Forces
- China Therapeutic Ultrasound Industry Life Cycle
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Therapy Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By High-Intensity Focused for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Low-Intensity Pulsed for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Lithotripsy Ultrasound for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Neuromodulation for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Modality for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Non-invasive for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Targeted Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Shock Wave for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Focused Beam for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Application Area for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Tumor Ablation for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Bone Healing for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Kidney Stones for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Brain Disorders for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Cancer Centers for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Orthopedic Clinics for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Urology Units for the Period 2022 - 2032F
- Historical Data and Forecast of China Therapeutic Ultrasound Market Revenues & Volume By Neuro Clinics for the Period 2022 - 2032F
- China Therapeutic Ultrasound Import Export Trade Statistics
- Market Opportunity Assessment By Therapy Type
- Market Opportunity Assessment By Modality
- Market Opportunity Assessment By Application Area
- Market Opportunity Assessment By End User
- China Therapeutic Ultrasound Top Companies Market Share
- China Therapeutic Ultrasound Competitive Benchmarking By Technical and Operational Parameters
- China Therapeutic Ultrasound Company Profiles
- China Therapeutic Ultrasound Key Strategic Recommendations
Market Covered
Segments analysed in this report are listed below.
By Therapy Type
- High-Intensity Focused
- Low-Intensity Pulsed
- Lithotripsy Ultrasound
- Neuromodulation
By Modality
- Non-invasive
- Targeted Therapy
- Shock Wave
- Focused Beam
By Application Area
- Tumor Ablation
- Bone Healing
- Kidney Stones
- Brain Disorders
By End User
- Cancer Centers
- Orthopedic Clinics
- Urology Units
- Neuro Clinics
